Page 5 - Oncology Program News Today

Additionally, for the first time, Newsweek has introduced new rankings for 'America's Best Children's Hospitals' in seven specialties, and Children’s Hospital

Afreen Idris Shariff, MD, MBBS, director at Duke Endo-Oncology Program, Duke Endocrinology, Duke Cancer Institute, discusses how e-consults are addressing specific endocrine immune-related adverse events from immune checkpoint inhibitors (ICIs), reducing time to appointment, and lowering the need for hospitalization.

J. Randolph (Randy) Hecht, MD, discusses barriers to treatment with CAR T-cell therapy in patients with solid tumors, highlighting various efforts that investigators are spearheading to address these unmet needs.

J. Randolph Hecht, MD,

/PRNewswire/ -- Hoag is proud to announce that Simon Khagi, M.D., F.A.C.P., a renowned, triple board-certified medical oncologist and neuro-oncologist...

Doha, Qatar: Hamad Medical Corporation s pioneering Cardio Oncology Program aims to become a beacon of excellence in the Middle East and beyond. The p...

Ocean Biomedical Inc (NASDAQ: OCEA) shared an update on its broad range of programs in malaria, fibrosis, and multiple cancers. Oncology Program:

Company receives further regulatory clarity from FDA on Phase 3 ENABLAR-2 study. Potential for enobosarm +/- abemaciclib accelerated approval pathway in metastatic breast cancer, if successful based... -Today at 06:31 am- MarketScreener

- Recently presented 36-month apitegromab extension data from Phase 2 TOPAZ trial demonstrate long-term substantial and sustained improvement of motor function and further strengthen conviction in...

David Ziegler, MD, PhD, discusses findings from the phase 2 FIREFLY-1 trial of tovorafenib in pediatric patients with low-grade glioma.